ArticleFrontiers in oncology2021

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.

Jiacheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.